Cite
HARVARD Citation
Alessandri, C. et al. (2004). Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Annals of the rheumatic diseases. 63 (10), pp. 1218-1221. [Online].